These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 23654079)
1. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency. Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079 [TBL] [Abstract][Full Text] [Related]
2. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients. Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386 [TBL] [Abstract][Full Text] [Related]
3. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age. Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715 [TBL] [Abstract][Full Text] [Related]
4. Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis. Ajdary S; Jafari-Shakib R; Riazi-Rad F; Khamesipour A J Infect; 2007 Jul; 55(1):75-8. PubMed ID: 17241668 [TBL] [Abstract][Full Text] [Related]
6. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD26 and CD30 in patients on hemodialysis. Nakao K; Nagake Y; Okamoto A; Ichikawa H; Yamamura M; Makino H Nephron; 2002 Jun; 91(2):215-21. PubMed ID: 12053056 [TBL] [Abstract][Full Text] [Related]
8. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications. Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490 [TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels. Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186 [TBL] [Abstract][Full Text] [Related]
10. T- helper 1 and 2 cytokine assay in patients with common variable immunodeficiency. Rezaei N; Aghamohammadi A; Kardar GA; Nourizadeh M; Pourpak Z J Investig Allergol Clin Immunol; 2008; 18(6):449-53. PubMed ID: 19123436 [TBL] [Abstract][Full Text] [Related]
11. Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis. Jafari-Shakib R; Shokrgozar MA; Nassiri-Kashani M; Malakafzali B; Nikbin B; Khamesipour A Acta Trop; 2009 Jan; 109(1):61-3. PubMed ID: 18983807 [TBL] [Abstract][Full Text] [Related]
12. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD30 in normal pregnancy, pre-eclampsia and recurrent pregnancy loss. Gharesi-Fard B; Jafarzadeh L; Zolghadri J; Haghbin H Iran J Immunol; 2012 Dec; 9(4):234-40. PubMed ID: 23268289 [TBL] [Abstract][Full Text] [Related]
15. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease. Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265 [TBL] [Abstract][Full Text] [Related]
16. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition. Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299 [TBL] [Abstract][Full Text] [Related]
17. Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency. Arandi N; Mirshafiey A; Abolhassani H; Jeddi-Tehrani M; Edalat R; Sadeghi B; Shaghaghi M; Aghamohammadi A Scand J Immunol; 2013 May; 77(5):405-12. PubMed ID: 23432692 [TBL] [Abstract][Full Text] [Related]
18. Plasma soluble CD30 level correlates negatively with age in children. Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967 [TBL] [Abstract][Full Text] [Related]
20. Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia. Wang H; Gu X; Li H; Yin L; Tao W; Yu J; Zhou Q; Mu H; Shen Y; Yao J; Liu L; Bi H; Yang R; Zhou Z Biomed Res Int; 2020; 2020():1279371. PubMed ID: 32337220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]